916,443 Shares in Bath & Body Works, Inc. $BBWI Bought by Capital International Investors

Key Points

• Capital International Investors opened a new position in Bath & Body Works, buying 916,443 shares valued at about $23.6 million and representing roughly 0.44% ownership at the end of the quarter.
• Bath & Body Works reported quarterly EPS of $2.05 (beating estimates) and revenue of $2.72 billion (down 2.3% YoY), issued Q1 2026 EPS guidance of 0.240–0.300 and FY 2026 guidance of 2.400–2.650, and declared a $0.20 quarterly dividend (4.3% yield).
• Multiple law firms have issued securities‑fraud class action notices covering a June 4, 2024–Nov 19, 2025 class period with mid‑March filing deadlines, increasing potential litigation risk and investor uncertainty.

Capital International Investors purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 916,443 shares of the company's stock, valued at approximately $23,608,000. Capital International Investors owned about 0.44% of Bath & Body Works at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. First Horizon Corp acquired a new position in shares of Bath & Body Works in the 3rd quarter valued at $29,000. Geneos Wealth Management Inc. lifted its stake in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after buying an additional 801 shares in the last quarter. Carolina Wealth Advisors LLC purchased a new position in shares of Bath & Body Works in the third quarter valued at approximately $54,000. Westfuller Advisors LLC acquired a new stake in Bath & Body Works during the 3rd quarter worth $56,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new position in Bath & Body Works during the third quarter worth about $56,000. Institutional investors and hedge funds own 95.14% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on BBWI. Barclays boosted their price objective on Bath & Body Works from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research note on Monday, March 2nd. Robert W. Baird set a $20.00 target price on Bath & Body Works in a research note on Wednesday, December 17th. JPMorgan Chase & Co. reduced their price objective on shares of Bath & Body Works from $26.00 to $15.00 and set a "neutral" rating on the stock in a report on Thursday, November 20th. Weiss Ratings restated a "hold (c-)" rating on shares of Bath & Body Works in a research note on Wednesday, January 21st. Finally, Guggenheim started coverage on shares of Bath & Body Works in a research report on Tuesday, December 9th. They set a "neutral" rating on the stock. Three equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $24.00.

Bath & Body Works Price Performance

BBWI opened at $18.77 on Friday. The stock has a market capitalization of $3.84 billion, a P/E ratio of 5.96, a P/E/G ratio of 2.00 and a beta of 1.48. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $34.66. The business has a 50 day simple moving average of $22.39 and a 200-day simple moving average of $23.24.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share for the quarter, beating analysts' consensus estimates of $1.77 by $0.28. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The business had revenue of $2.72 billion during the quarter, compared to analysts' expectations of $2.59 billion. During the same quarter last year, the business posted $2.09 earnings per share. The business's revenue for the quarter was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 6th. Shareholders of record on Friday, February 20th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date of this dividend was Friday, February 20th. Bath & Body Works's dividend payout ratio (DPR) is presently 25.40%.

Key Headlines Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Telsey Advisory raised its target for Bath & Body Works (BBWI) to $25 while keeping a Market Perform rating — a modest positive signal that some analysts see valuation upside, but the unchanged rating limits near‑term bullish impact. Telsey Advisory Raises Bath & Body Works (BBWI) Target to $25, Maintains Market Perform Rating
• Negative Sentiment: Widespread securities‑fraud class action notices and lead‑plaintiff solicitations have been issued by numerous law firms, citing alleged misstatements during a class period from June 4, 2024 to Nov 19, 2025; multiple firms are urging investors to file before mid‑March deadlines (March 13–16). This increases the likelihood of litigation, potential settlements, legal costs, and investor uncertainty—common near‑term downward pressure on shares. Representative notices: Glancy Prongay Wolke & Rotter; Pomerantz; Bernstein Liebhard; Schall Law Firm; DJS Law Group; Rosen; Bragar Eagel & Squire; Bronstein Gewirtz & Grossman; Faruqi & Faruqi; Levi & Korsinsky. Glancy Prongay Wolke & Rotter LLP deadline alert Pomerantz investor alert Bernstein Liebhard reminder Schall Law Firm notice DJS Law Group notice

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.